Structure Therapeutics Inc. develops drug candidates using proprietary PEGylation and advanced polymer conjugate technologies to improve drug characteristics such as retention and solubility. The company serves pharmaceutical companies and has developed the first inhalable non-injectable insulin, Exubera.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.